The Effectiveness and Safety of Huangqi Xixin Decoction for Cough Variant Asthma: A Systematic Review and Meta-Analysis

Overview

Journal Evid Based Complement Alternat Med

Specialty Rehabilitation Medicine

Date 2022 Oct 4

PMID 36193126

Authors

Cong Wang

Qingqing Xia

Beina Hu

Weilong Jiang

Huizhe Zhang

Affiliations

Soon will be listed here.

Abstract

Objective: A comprehensive and systematic review is needed to evaluate the safety and effectiveness of Huangqi Xixin decoction (HQXXD) for cough variant asthma (CVA). In this systematic review, we comprehensively interrogate the safety and effectiveness of HQXXD for CVA.

Methods: An overall search for studies in main English and Chinese electronic databases from their inception to June 30, 2022, was performed. Randomized controlled trials (RCTs) involving HQXXD for CVA were included. According to Cochrane Reviewer's Handbook, the risk of bias related to the included studies was evaluated. A meta-analysis using RevMan 5.4 software from the Cochrane Collaboration was used to integrate the outcomes of the included RCTs.

Results: A systematic review and meta-analysis were conducted using the seven eligible RCTs that had been retrieved. The included RCT-related risk of bias was evaluated. According to the findings of the meta-analysis, the HQXXD group had significantly higher total effective rates of clinical efficacy and airway responsiveness, and a significantly lower recurrence rate in comparison with the conventional Western medicine treatment group.

Conclusion: In the treatment of CVA patients, HQXXD is safe and effective, which benefits clinical efficacy and airway responsiveness, reduces the recurrence rate, and has no adverse effects.

Citing Articles

Integrative analysis of the efficacy and pharmacological mechanism of Xuefu Zhuyu decoction in idiopathic pulmonary fibrosis via evidence-based medicine, bioinformatics, and experimental verification.

Zhang H, Hua H, Liu J, Wang C, Zhu C, Xia Q Heliyon. 2024; 10(19):e38122.

PMID: 39416822 PMC: 11481653. DOI: 10.1016/j.heliyon.2024.e38122.

Efficacy of β2-adrenergic receptor agonist combined with corticosteroid in the treatment of children with cough variant asthma.

Cao J, Wang Y, Deng X World J Clin Cases. 2023; 11(31):7610-7618.

PMID: 38078144 PMC: 10698450. DOI: 10.12998/wjcc.v11.i31.7610.

References

Higgins J, Thompson S . Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11):1539-58. DOI: 10.1002/sim.1186. View

Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372:n71. PMC: 8005924. DOI: 10.1136/bmj.n71. View

Stewart L, Moher D, Shekelle P . Why prospective registration of systematic reviews makes sense. Syst Rev. 2012; 1:7. PMC: 3369816. DOI: 10.1186/2046-4053-1-7. View

Yi F, Han L, Liu B, Zhang X, Xue Y, Luo W . Determinants of response to bronchodilator in patients with cough variant asthma- A randomized, single-blinded, placebo-controlled study. Pulm Pharmacol Ther. 2020; 61:101903. DOI: 10.1016/j.pupt.2020.101903. View

Zhang L, Liu S, Li M, Xu X . Diagnostic value of fractional exhaled nitric oxide in cough-variant asthma: an updated meta-analysis. J Asthma. 2019; 57(3):335-342. DOI: 10.1080/02770903.2019.1568452. View

Gu C, Peng W, Wang Z, Xu Y, Han D, Zhou X . Suhuang Zhike Capsules for the Treatment of Cough Variant Asthma: A Meta-analysis. Evid Based Complement Alternat Med. 2021; 2020:9485746. PMC: 7790581. DOI: 10.1155/2020/9485746. View

Miao Q, Wei P, Fan M, Zhang Y . Clinical study on treatment of cough variant asthma by Chinese medicine. Chin J Integr Med. 2013; 19(7):539-45. DOI: 10.1007/s11655-013-1508-5. View

Higgins J, Altman D, Gotzsche P, Juni P, Moher D, Oxman A . The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011; 343:d5928. PMC: 3196245. DOI: 10.1136/bmj.d5928. View

Xia Q, Liu M, Li H, Tian L, Qi J, Zhang Y . Network Pharmacology Strategy to Investigate the Pharmacological Mechanism of HuangQiXiXin Decoction on Cough Variant Asthma and Evidence-Based Medicine Approach Validation. Evid Based Complement Alternat Med. 2020; 2020:3829092. PMC: 7647767. DOI: 10.1155/2020/3829092. View

10.

Bao W, Chen Q, Lin Y, Liu H, Zhao G, Chen Z . Efficacy of procaterol combined with inhaled budesonide for treatment of cough-variant asthma. Respirology. 2013; 18 Suppl 3:53-61. DOI: 10.1111/resp.12169. View

11.

Gao J, Wu F, Wu S, Yang X . Inflammatory Subtypes in Classic Asthma and Cough Variant Asthma. J Inflamm Res. 2020; 13:1167-1173. PMC: 7765682. DOI: 10.2147/JIR.S269795. View

12.

Low Z, Yeo K, Sharma V, Leung G, McIntyre R, Guerrero A . Prevalence of Burnout in Medical and Surgical Residents: A Meta-Analysis. Int J Environ Res Public Health. 2019; 16(9). PMC: 6539366. DOI: 10.3390/ijerph16091479. View

13.

Tagaya E, Kondo M, Kirishi S, Kawagoe M, Kubota N, Tamaoki J . Effects of regular treatment with combination of salmeterol/fluticasone propionate and salmeterol alone in cough variant asthma. J Asthma. 2014; 52(5):512-8. DOI: 10.3109/02770903.2014.975358. View

14.

Zhang Y, Gu L, Xia Q, Tian L, Qi J, Cao M . Radix Astragali and Radix Angelicae Sinensis in the Treatment of Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-analysis. Front Pharmacol. 2020; 11:415. PMC: 7203419. DOI: 10.3389/fphar.2020.00415. View

15.

Moher D, Booth A, Stewart L . How to reduce unnecessary duplication: use PROSPERO. BJOG. 2014; 121(7):784-6. DOI: 10.1111/1471-0528.12657. View

16.

Kyou-Hwan H, Ki Haeng C, Cui S, Lily L, Jaejong K . Effectiveness and safety of traditional Chinese herbs in children with cough variant asthma: a systematic review and Meta-analysi. J Tradit Chin Med. 2021; 41(5):661-668. DOI: 10.19852/j.cnki.jtcm.2021.05.001. View

17.

Niimi A . Cough variant asthma. Nihon Rinsho. 2018; 74(10):1693-1697. View

18.

An T, Kim J, Choi E, Jang S, Lee H, Kang H . Clinical Characteristics of Chronic Cough in Korea. Tuberc Respir Dis (Seoul). 2020; 83(1):31-41. PMC: 6953492. DOI: 10.4046/trd.2019.0018. View

19.

Morice A, Millqvist E, Bieksiene K, Birring S, Dicpinigaitis P, Ribas C . ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Respir J. 2019; 55(1). PMC: 6942543. DOI: 10.1183/13993003.01136-2019. View

20.

Zhang S, Chen Z, Tang Y, Duan J, Yao K . Efficacy and Safety of Decoction for Patients with Coronary Heart Disease: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med. 2021; 2021:9931826. PMC: 8494581. DOI: 10.1155/2021/9931826. View